...and may limit effectiveness of these breast cancer detection methods Women who take combined hormone therapy for about five years have a higher risk of abnormal mammograms and breast biopsies. This, in turn, may decrease the effectiveness of these methods of detecting … [Read more...] about HRT Can Lead to Abnormal Mammograms, Biopsies…
FDA Approves Wyeth Antidepressant
Read This FDA Press Release to the Partridge Family Theme Song, "Come on Get Happy" "Trav'lin' along, here's a song that we're singing Come on get happy A whole lotta lovin' is what we'll be bringing We'll make you happy We'll make you happy Come on get happy!" Wyeth … [Read more...] about FDA Approves Wyeth Antidepressant
WHI Estrogen-Plus-Progestin Trial…
...3 Years Later Increased risk for adverse cardiovascular outcomes and invasive breast cancer — and reduced risk for fractures and colorectal cancer — did not persist after women discontinued HT. In the summer of 2002, the Women’s Health Initiative (WHI) randomized trial … [Read more...] about WHI Estrogen-Plus-Progestin Trial…
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
JAMA Publishes HRT Study JAMA. 2008;299(9):1036-1045. Context: The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its … [Read more...] about Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
The Women's Health Initiative (WHI) Trial Team Gerardo Heiss, MD; Robert Wallace, MD; Garnet L. Anderson, PhD; Aaron Aragaki, MS; Shirley A. A. Beresford, PhD; Robert Brzyski, MD; Rowan T. Chlebowski, MD; Margery Gass, MD; Andrea LaCroix, PhD; JoAnn E. Manson, MD; Ross L. … [Read more...] about Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin